Volume 14, Number 3—March 2008
Research
Mycobacterium ulcerans Disease, Peru
Humberto Guerra*, Juan Carlos Palomino†, Eduardo Falconí*‡, Francisco Bravo*, Ninoska Donaires*, Eric Van Marck§, and Françoise Portaels†
Table 2
Diagnostic laboratory studies on patients with Buruli ulcer, Peru*
| Patient no. | ITM no. | AFB in smear (ZN) | Histopathologic changes | AFB in histologic sections | IS2404 PCR | Culture |
|---|---|---|---|---|---|---|
| 1 | None | Positive | Necrosis of fat | Positive | ND | ND |
| 2 | 96–0729 | Positive | Necrosis of fat | Positive | Positive | Contaminated |
| 3 | 01–0720 | Positive | Necrosis of fat | Positive | Positive | Negative |
| 4 | 02–1536 | Positive | Necrosis of fat | Positive | Positive | Contaminated |
| 5 | 02–1877 | Negative (only 1 AFB seen) | Necrosis of fat + granulomatous infiltrate | Positive | Positive | Negative |
| 6 | 04–0872 | Positive | Necrosis of fat | Positive | Positive | Negative |
| 7 | 05–2249 05–2411 | Positive | Necrosis of fat + inflammation | Positive | Positive | Negative |
| 8 | None | Positive | Necrosis of fat + inflammation | Positive | Positive | Negative |
*ITM, Institute of Tropical Medicine; AFB, acid-fast bacilli; ZN, Ziehl-Neelsen staining; ND, not done.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.